Vaccination against hepatitis A in patients with chronic liver disease

Irphan Gaslightwala, Edmund J. Bini

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with underlying chronic liver disease. HAV vaccination is effective and safe, although the vaccine is less immunogenic in patients with advanced liver disease. Despite recommendations to immunize patients with chronic liver disease, rates of HAV vaccination remain low. thus highlighting the need for public health programs to increase awareness about HAV vaccination.

Original languageEnglish
Pages (from-to)49-53
Number of pages5
JournalCurrent Hepatitis Reports
Issue number2
StatePublished - May 2006
Externally publishedYes


Dive into the research topics of 'Vaccination against hepatitis A in patients with chronic liver disease'. Together they form a unique fingerprint.

Cite this